Concepedia

Jan Sterz

JS

Statistics

Publications

13

Citations

813

H-Index

12

Active since

2005

Affiliations

Charité - Universitätsmedizin Berlin(Current)

University Hospital Ulm

University Medical Center Hamburg-Eppendorf

Universität Hamburg

Jan Sterz is an author at Charité - Universitätsmedizin Berlin specializing in medicine, oncology, and multiple myeloma.

Publications per year

2005–2012

13

Publications

13

Bortezomib inhibits human osteoclastogenesis

Ivana von Metzler, Holger Krebbel, Monica Hecht et al. · Leukemia · 2007 · 205 citations

Medicine, Cancer Biology, Bone Metabolism +10

Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma

Christian Jakob, Karl Egerer, Peter Liebisch et al. · Blood · 2006 · 127 citations

Life Sciences, Molecular Biology, Oncology +16

Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma

Ulrike Heider, Ivana von Metzler, Martin Kaiser et al. · European Journal Of Haematology · 2007 · 96 citations

Medicine, Molecular Biology, Oncology +16

The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma.

Martin Kaiser, Ivana Zavrski, Jan Sterz et al. · PubMed · 2006 · 85 citations

Medicine, Oncology, Pharmacology +17

Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma

Ulrike Heider, Martin Kaiser, Jan Sterz et al. · European Journal Of Haematology · 2005 · 80 citations

Medicine, Oncology, Pharmacology +15

1–5 of 13